Skip to main content

Table 2 Univariate analysis to identify factors that affect survival and 1- and 3-year overall survival rates

From: Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study

Variables

p value

1-year

3-year

Age

   

 <75

0.958

58.3 %

38.9 %

 ≥75

 

70.3 %

35.2 %

PS

   

 ≤1

0.163

70.5 %

45.7 %

 ≥2

 

33.3 %

T-stage

   

 T2

0.494

62.4 %

21.4 %

 T3

 

72.9 %

48.6 %

Location 1

   

 Lower lobe

0.250

39.4 %

19.7 %

 Middle and upper lobe

 

81.9 %

19.0 %

Location 2

   

 Near the pulmonary hilum

0.235

75.0 %

75.0 %

 Peripheral

 

61.2 %

17.5 %

Pathology

   

 Squamous

0.728

61.4 %

28.1 %

 Adeno

 

79.5 %

53.0 %

BED (Gy)

   

 <80 Gy

0.087

55.9 %

 ≥80 Gy

 

76.2 %

63.5 %

  1. Abbreviations: BED biological effective dose